EXODUS BIO automatic exosome isolation system for high speed, purity and yield
01 December, 2024The EXODUS series of automatic exosome isolation systems represents an advanced technological approach for laboratories engaged in extracellular vesicle (EV) research, particularly those focused on exosomes.
Wearable microlasers measure biomarkers in sweat
18 July, 2024By encapsulating a microlaser in liquid crystal droplets and embedding the liquid within a soft hydrogel film, researchers created a device which can provide highly accurate biomarker readings within minutes.
Liquid biopsy to inform non-small cell lung cancer treatment
18 October, 2023A novel liquid biopsy test may help determine which patients with non-small cell lung cancer that has spread beyond the lungs are most likely to benefit from targeted, high-dose radiation.
Spinal fluid test can detect Lewy body disease early
28 July, 2023Until recently, it was not possible to determine with certainty whether a person with movement difficulties or cognitive impairments had Lewy bodies in the brain until after their death.
Liquid biopsy to optimise prostate cancer treatment
10 February, 2023US investigators have developed a nanotechnology-based test that can detect and profile prostate cancers — even in microscopic amounts.
Urine test for bladder cancer could replace cystoscopies
29 April, 2022The test will use highly sensitive liquid biopsy technology, in conjunction with a panel of biomarkers, to detect the presence of bladder cancer.
Lab-on-a-strip test for dengue fever developed
22 April, 2022Researchers have used a new diagnostic kit called Cygnus to detect dengue fever, with significantly improved rates over lateral flow testing kits.
'Lab in a backpack' enables portable COVID-19 testing
28 January, 2022Costing just US$51 to make, the compact kit could offer a testing solution for areas with little access to well-equipped labs or trained personnel.
Rapid antigen tests available now, ATAGI approves boosters
01 November, 2021 by Lauren DavisThe TGA has approved a total of nine COVID-19 rapid antigen tests, while vaccine booster shots will be available to Australian adults from 8 November.
TGA supports at-home COVID-19 testing from 1 November
29 September, 2021 by Lauren DavisAt-home rapid antigen tests for COVID-19 will be available in Australia from 1 November 2021, subject to individual tests being approved as safe and effective.
Blood test monitors cancer treatment outcomes in real time
21 June, 2021Cancer patients who are undergoing targeted therapy can look forward to a new blood test that could tell their doctors whether the treatment is working.
BioVision ExoPure Exosome Isolation Kits
04 March, 2021BioVision's ExoPure Exome Isolation Kits offer a fast and convenient method of exosome isolation and purification at high yields with intact morphology from body fluids, cell media, serum and plasma, urine and stem cell media.
Rapid COVID-19 tests to be rolled out in Africa
30 October, 2020The rollout of new, World Health Organization-approved, antigen-based rapid diagnostic tests for COVID-19 in Africa is expected to significantly boost testing capacity.
PixCell Medical HemoScreen haematology analyser
08 October, 2020PixCell Medical has received regulatory approval from the Therapeutic Goods Administration (TGA) for its HemoScreen device, designed to make the most common complete blood count (CBC) test accessible locally when results are needed quickly.
Graphene oxide enables rapid infection detection
11 August, 2020Researchers have developed a graphene oxide-based sensor platform to detect acute infections within minutes.
